Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
CALIGAN PARTNERS LP | 02-14-2024 | 12-31-2023 | 11 | 296,522,630 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
LIQUIDIA CORP | COM NEW | 1 | $124,642,168 | 10,360,945 | 0.04 | 0.04 | 1,117,318 | 12.09 | 12-31-2023 |
ALIMERA SCIENCES INC | COM NEW | 2 | $72,727,865 | 16,835,154 | 0.02 | 0.00 | 16,356,377 | 3416.28 | 12-31-2023 |
ANIKA THERAPEUTICS INC | COM | 3 | $24,503,618 | 1,081,360 | 0.01 | 0.01 | 361,069 | 50.13 | 12-31-2023 |
EXELIXIS INC | COM | 4 | $21,848,413 | 910,730 | 0.01 | 0.01 | 0 | 0.00 | 12-31-2023 |